TEAD Inhibition in Combination to Tackle Targeted Therapy Resistance in Oncology •Evaluating the context in which the Hippo pathway confers resistance to targeted therapies •Considering potential pathways and drugs to use in combination with TEAD inhibit

Time: 4:15 pm
day: Conference Day One

Details:

  • Evaluating the context in which the Hippo pathway confers resistance to targeted therapies 
  • Considering potential pathways and drugs to use in combination with TEAD inhibitors
  • Exploring future steps at Ikena 

Speakers: